mutagenic events of methylating agent exposure, including O 6 -alkylguanine DNA-alkyltransferase (ATase) provides those events known to occur within the colon and rectum. We protection against the toxic, mutagenic and carcinogenic have investigated whether or not there is such an association effects of alkylating agents, principally by removing the probetween the levels of ATase activity in normal and tumour mutagenic lesion O 6 -alkylguanine from DNA. Differences colorectal tissue and the presence of K-ras mutations (and of in ATase activity in human tissue may thus determine GC→AT transitions in particular) in colorectal tumour tissue mutational susceptibility. As GC→AT transitions, which from the same patient. can be induced by O 6 -alkylguanine in DNA, are commonly observed in the K-ras oncogene of alkylating agent induced animal tumours and in human colorectal tumours, we have Materials and methods examined whether differences in ATase activity may affect with a K-ras mutation in colorectal tissue and more sigmoid colon (n ϭ 21), transverse colon (n ϭ 2) or hepatic flexure (n ϭ 1) specifically a GC→AT transition (but not a transversion and stored at Ϫ70°C.
mutation) was significantly lower than that in individuals
K-ras mutation analysis without a mutation (P Ͻ 0.01). Thus, individuals with low DNA was extracted from normal and tumour tissue using phenol-based ATase activity in normal tissue (i.e. below the median) were methods, and codon 12 and 13 K-ras mutations were detected using a at increased risk of having a transition (OR 10.1; 95% CI PCR based restriction endonuclease-site mutation assay followed by DNA sequencing (8) .
Introduction mean Ϯ SD in Table I . Differences in mutational frequencies were investigated using the chi-square and Fishers exact tests.
The molecular events leading to the formation of colorectal tumours have become well characterized, but the causative agents remain to be identified (1, 2) . We have demonstrated Results previously (3) that DNA from human colorectal tissue contains ATase activity and K-ras mutations in colorectal tissue the pro-mutagenic lesion O 6 -methylguanine (O 6 MeG*) which is a marker of exposure to methylating agents of the kind that ATase activity was detected in all samples with levels ranging can produce colorectal tumours in experimental animals (4).
from 52-342 and 35-451 fmol/mg protein in normal and tumour O 6 -MeG in DNA can be repaired by O 6 -alkylguanine DNAtissue, respectively ( Figure 1 ). Inter-individual variation in alkyl-transferase (ATase) in a stoichiometric process which ATase activity was thus 6.6-and 12.9-fold in normal and results in the autoinactivation of the repair protein (5). However, tumour tissue, respectively. K-ras mutations were found in 23 if it is not repaired before DNA replication, thymine can be individuals: six mutations were found in macroscopically normal tissue (8) . The frequency of mutations in tumour tissue was significantly higher than that found in normal tissue (χ 2 ϭ *Abbreviations: O 6 -MeG, O 6 -methylguanine; ATase, O 6 -alkylguanine DNAalkyltransferase.
5.36, P Ͻ 0.05). median (Table II) : 42% (13/31) versus 7% (2/30), respectively CI 0.2-9.9) in their colorectal tissue (Table II) . this was done, there were still significantly more GC→AT e Significantly different from no mutation group (P ϭ 0.006).
transitions in individuals whose ATase activity was below the f Significantly different from no mutation group (P ϭ 0.007).
median (112 fmol/mg protein) than in individuals whose ATase activity was above the median (Table II) : 27% (8/27) versus 4% (1/28), respectively (Fishers exact test, P ϭ 0.01). IndiRelationship between ATase activity in normal tissue and K-ras viduals with low ATase activity in normal tissue (i.e. below mutations the median) were at increased risk of having a GC→AT The levels of ATase activity in different groups, subdivided transition in their tumour tissue (OR 11.4; 95% CI 1.2-522.6: upon whether the K-ras oncogene was mutated or not, are Table II ). shown in Figure 1A . ATase activity in normal tissue was
Relationship between ATase activity in tumour tissue and significantly lower in individuals with a mutation than in those K-ras mutations individuals without a K-ras mutation (P ϭ 0.007; Table I ).
As the association between ATase activity in normal tissue Since ATase would be expected to reduce specifically the and K-ras mutations may have been the result of the disease formation of GC→AT transitions, we further analysed the data process itself, we examined the relationship between ATase based on the type of the mutations observed in the Kactivity in tumour tissue and K-ras mutations ( Figure 1B ). ras oncogene (Figure 1 ): ATase activity in individuals with Though ATase activity in tumour tissue from individuals was GC→AT transitions was significantly lower than in the lower in individuals with a mutation or with a GC→AT remaining individuals who lacked a mutation (P ϭ 0.006: transition, this difference was not statistically significant Table I ). ATase activity in individuals with a GC→CG or (Table I) . ATase levels from individuals with a transversion GC→TA transversion was not significantly different from that mutation were not different from that found in those without found in individuals without a mutation. a mutation. Stratification of the data based upon the median ATase Stratification of the data based upon the median ATase activty in normal tissue (104 fmol/mg protein) indicated that activity in tumour tissue (126 fmol/mg protein) indicated that there were significantly more GC→AT transitions in individuals whose ATase activity was below the median than above the there was no difference in the frequency of GC→AT transitions (or GC→CG/TA transversions) in individuals whose ATase (17) . Environmental influences are clearly important, since exposure to a number of agents can either transiently induce activity was above or below the median (Table II) : 24% (9/28) and 15% (4/27) of individuals with ATase activity above (e.g. cigarette smoke, ionising radiation, alkylating agents and 2-acetylaminofluorene: 18-21) or reduce (e.g. alkylating agents or below the median respectively had a GC→AT transition (χ 2 ϭ 0.78, P ϭ 0.38). There was no detectable association and pseudosubstrates: 22-24) ATase expression in different cells and tissues. In a previous study we found an inverse between the levels of tumour ATase activity and the risk of having a transition or transversion mutation (Table II) .
correlation between ATase and O 6 -MeG levels in human bladder samples obtained from individuals living in the Nile Delta region of Egypt who are exposed chronically to NDiscussion nitroso compounds (9) indicating that this exposure, in part, Susceptibility to alkylating agent induced carcinogenesis in influences ATase levels. However, in the present sample model systems depends upon the interaction between the extent set, we found no association between current exposure to of exposure (which potentially determines initial levels of DNA methylating agents (indicated by the presence or absence of damage), DNA repair enzyme capacity (which determines O 6 -MeG) and K-ras mutations (8), and also no relationshp the persistence of such damage) and the extent of cellular between O 6 -MeG levels and ATase activity (data not shown). proliferation (as a route to the fixation of mutagenic lesions:
This suggests that the observed differences in ATase activity 10,11). In humans, risk factors that determine whether an do not simply reflect differences in levels of exposure to individual is susceptible to the carcinogenic effects of alkylatalkylating agents. ing agents are still largely unknown, but given the known Our data are consistent with the known action of ATase in function of ATase, the large inter-individual variations in its repairing lesions (principally O 6 -MeG) that induce GC→AT activity observed in different human tissues may play a role transitions and suggests that alkylating agent exposure is in determining cancer risk (12) (13) (14) . One study has suggested involved in the aetiology of those tumours which contain a that lung cancer risk is higher in individuals with low ATase GC→AT transition mutation in the K-ras oncogene. Furtheractivity as fibroblast ATase activity was lower in lung cancer more, as O 6 -MeG is a highly cytotoxic lesion probably as a patients than in healthy controls (15) .
result of the action of mismatch repair enzymes on O 6 -MeG-T In this study, we have found an inverse association between mismatches produced upon DNA replication (25), exposure to the levels of ATase activity in normal colorectal tissue (i.e. alkylating agents may also be an aetiologic factor in the the target tissue) and the risk of having a K-ras mutation in mutation of mismatch repair proteins and, consequently, the the same tissue. Though this association might have resulted development of those tumours with microsatellite instability from the disease process itself or the presence of potential (26) . The sources of such alkylating agent exposure have yet confounding factors such as p53 mutations (16), a similar to be determined, but it is known that bile acids can be association was also found when we examined the relationship nitrosated to give carcinogens (27) and bacterially mediatedbetween ATase levels in normal tissue and mutations detected in endogenous nitrosation reactions within the colon generate tumour tissue. Additionally, as we did not detect a relationship large amounts of compounds that are detected using procedures between tumour ATase levels and mutational risk, this suggests that detect N-nitroso compounds (28) . The colon and rectum that the level of ATase activity in normal tissue is indeed a factor are thus potentially exposed chronically to a number of different involved in determining susceptibility to the development of alkylating agents. A reduction in exposure to these alkylating a K-ras mutation. Further analytical studies, however, are agents or increased ATase expression may therefore be expected needed to confirm this hypothesis and to show whether to reduce the incidence of, at least, K-ras mutated colorectal individuals with low ATase activity are at increased risk of tumours. developing colorectal cancer.
Given that ATase levels may play a role in determining
